Company Filing History:
1 out of 4 
1 out of 64 Years Active: 1995-1997
Title: The Innovations of George V Avvakumov
Introduction
George V Avvakumov is a notable inventor based in London, Canada. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of steroid-binding variants of human corticosteroid binding globulin. With a total of 2 patents, his work has implications for the treatment of inflammation in mammals.
Latest Patents
Avvakumov's latest patents include two innovative approaches to corticosteroid binding globulin. The first patent describes a novel steroid-binding variant of human corticosteroid binding globulin, where one or more glycosylation sites, excluding the site at amino acid position 238, have been functionally disrupted. This variant is complexed with an anti-inflammatory ligand to treat inflammation in mammals. The second patent similarly focuses on DNA encoding variants of human corticosteroid binding globulin, emphasizing the same functional disruptions and their therapeutic applications.
Career Highlights
Throughout his career, Avvakumov has worked with prominent companies in the biopharmaceutical sector. Notably, he has been associated with Allelix Biopharmaceutical Inc. and Allelix Biopharmaceuticals Inc. His expertise in the field has allowed him to contribute to significant advancements in drug development.
Collaborations
One of Avvakumov's notable collaborators is Geoffrey L Hammond. Their partnership has likely fostered innovative research and development in their shared field of expertise.
Conclusion
George V Avvakumov's contributions to biopharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of inflammation.